DOCN financial statements and SEC filings
DOCN annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $901.43M | $156.99M | $259.26M | 10-K |
| 2024-12-31 | $780.62M | $91.01M | $84.49M | 10-K |
| 2023-12-31 | $692.88M | $11.90M | $19.41M | 10-K |
| 2022-12-31 | $576.32M | -$25.70M | -$27.80M | 10-K |
| 2021-12-31 | $428.56M | -$11.19M | -$19.50M | 10-K |
| 2020-12-31 | $318.38M | -$15.79M | -$43.57M | 10-K/A |
DOCN annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $1.84B | $1.87B | -$28.69M | 10-Q |
| 2024-12-31 | $1.64B | $1.84B | -$202.96M | 10-K |
| 2023-12-31 | $1.46B | $1.77B | -$313.70M | 10-K |
| 2022-12-31 | $1.82B | $1.77B | $47.57M | 10-K |
| 2021-12-31 | $2.10B | $1.52B | $578.20M | 10-K/A |
| 2020-12-31 | $430.25M | $329.27M | -$72.09M | 10-K |
DOCN annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $309.60M | -$129.09M | -$216.91M | 10-K |
| 2024-12-31 | $282.73M | -$178.17M | -$76.45M | 10-K |
| 2023-12-31 | $234.94M | -$119.30M | -$468.90M | 10-K |
| 2022-12-31 | $195.15M | -$106.39M | -$610.36M | 10-K |
| 2021-12-31 | $133.11M | -$97.07M | $1.59B | 10-K |
| 2020-12-31 | $58.46M | -$98.36M | $124.03M | 10-K/A |